Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04KYB
|
||||
Former ID |
DIB007838
|
||||
Drug Name |
ASCJ-9 topical
|
||||
Synonyms |
Dimethylcurcumin; ASC-JMX1; ASCJ-9; ASCJ-9 (systemic), AndroScience; ASCJ-9 (topical), AndroScience; Androgen antagonist (alopecia/acne), AndroScience; Androgen receptor degradation enhancers (oral, spinal bulbar muscular atrophy), AndroScience
|
||||
Indication | Alopecia [ICD9: 704.09; ICD10:L65.9] | Phase 2 | [523346] | ||
Company |
AndroScience
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(c(ccc(c1)/C=C/C(=O)CC(=O)/C=C/c1cc(c(cc1)OC)OC)OC)OC
|
||||
CAS Number |
CAS 52328-98-0
|
||||
Target and Pathway | |||||
Target(s) | Androgen receptor | Target Info | Enhancer | [532450] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.